A carregar...

Oxidative Stress and Proteasome Inhibitors in Multiple Myeloma

Multiple myeloma is a form of plasma cell neoplasm that accounts for approximately 10% of all hematological malignancies. Recently, several novel drugs have been discovered that almost doubled the overall survival of multiple myeloma patients. One of these drugs, the first-in-class proteasome inhibi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacol Res
Main Authors: Lipchick, Brittany C., Fink, Emily E., Nikiforov, Mikhail A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044866/
https://ncbi.nlm.nih.gov/pubmed/26827824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2016.01.029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!